NYSE
11 hours, 55 minutes ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $575,000 through a pre-arranged Rule 10b5-1 trading plan.

NYSE
1 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 26, 2025, executed under a Rule 10b5-1 trading plan.

NYSE
2 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $12.55 per share on June 25, 2025, as part of a pre-arranged Rule 10b5-1 trading plan.

NYSE
3 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged 10b5-1 Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock at an average price of $12.4876 per share, executed under a Rule 10b5-1 trading plan.

NYSE
4 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged 10b5-1 Plan
UiPath CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 23, 2025, through a pre-arranged 10b5-1 trading plan.

NYSE
7 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Reports Sale of 45,000 Shares Under Pre-Arranged 10b5-1 Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 20, 2025, executed under a pre-arranged Rule 10b5-1 trading plan.

NYSE
9 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 18, 2025, executed under a Rule 10b5-1 trading plan.

NYSE
10 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged 10b5-1 Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 17, 2025, executed under a pre-arranged Rule 10b5-1 trading plan.

NYSE
11 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 90,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 90,000 Class A Common Stock shares through a Rule 10b5-1 trading plan.

NYSE
15 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells $1.16 Million in Company Stock Under Pre-Arranged Plan
UiPath, Inc. CEO and Chairman Daniel Dines executed the sale of 90,000 shares of Class A Common Stock over two days in June 2025, totaling approximately $1.16 million, as part of a pre-established Rule 10b5-1 trading plan.

NYSE
17 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $593,491 under a Rule 10b5-1 trading plan.
Worse than expected
 

NYSE
18 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $13.08 per share, executed under a Rule 10b5-1 trading plan.

NYSE
21 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $589,779, executed under a Rule 10b5-1 trading plan.

NYSE
22 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines has sold 45,000 shares of Class A Common Stock for approximately $592,492 under a Rule 10b5-1 trading plan.
Worse than expected
 

NYSE
23 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 4, 2025, executed under a Rule 10b5-1 trading plan.

NYSE
24 days, 12 hours ago 
PATH
Uipath, INC
10-Q: UiPath Reports Q1 2025 Revenue Growth Amidst Strategic Shift to AI and Cloud, Narrows Net Loss
UiPath, a leader in enterprise automation software, announced a 6% increase in total revenue to $356.6 million and a 12% rise in Annualized Renewal Run-Rate (ARR) to $1.69 billion for the first quarter ended April 30, 2025, while significantly narrowing its net loss.

NYSE
24 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath, Inc. CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock on June 3, 2025, executed under a Rule 10b5-1 trading plan.

NYSE
25 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under Pre-Arranged Trading Plan
UiPath CEO and Chairman Daniel Dines reported the sale of 45,000 shares of Class A Common Stock for approximately $13.31 per share, executed under a Rule 10b5-1 trading plan.

NYSE
29 days, 13 hours ago 
PATH
Uipath, INC
8-K: UiPath Exceeds Q1 Fiscal 2026 Expectations with Strong ARR Growth and Agentic Automation Platform Launch
UiPath, a global leader in agentic automation, reported first quarter fiscal 2026 financial results that surpassed guidance, driven by robust ARR growth and the successful launch of its next-generation agentic automation platform.
Better than expected
 

NYSE
43 days, 12 hours ago 
PATH
Uipath, INC
SCHEDULE 13G: Bank of America Discloses 5.6% Stake in UiPath, Inc. Class A Common Stock
Bank of America Corporation has filed a Schedule 13G, reporting beneficial ownership of 5.6% of UiPath, Inc.'s Class A common stock as of March 31, 2025.

NYSE
44 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath's CEO and Chairman, Daniel Dines, sold 45,000 shares of Class A Common Stock at an average price of $13.176 per share on May 14, 2025, under a pre-arranged 10b5-1 trading plan.

NYSE
45 days, 8 hours ago 
PATH
Uipath, INC
DEFA14A: UiPath, Inc. Files Definitive Proxy Statement with SEC
UiPath, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) related to its upcoming shareholder meeting.

NYSE
45 days, 12 hours ago 
PATH
Uipath, INC
DEF: UiPath Sets Date for 2025 Annual Stockholders Meeting, Outlines Key Proposals
UiPath will hold its Annual Meeting of Stockholders virtually on June 26, 2025, to vote on director elections, executive compensation, and the ratification of KPMG LLP as the independent auditor.
Worse than expected
 

NYSE
45 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock at an average price of $13.1224, according to a Form 4 filing.

NYSE
46 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock at an average price of $12.8332, pursuant to a pre-arranged 10b5-1 trading plan.

NYSE
49 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath's CEO and Chairman, Daniel Dines, sold 45,000 shares of Class A Common Stock at an average price of $12.5076, according to a Form 4 filing.

NYSE
50 days, 12 hours ago 
PATH
Uipath, INC
8-K: UiPath Director Laela Sturdy to Resign from Board at 2025 Annual Meeting
Laela Sturdy will resign from UiPath's Board of Directors prior to the 2025 Annual Meeting of Stockholders.

NYSE
50 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath's CEO and Chairman, Daniel Dines, sold 45,000 shares of Class A Common Stock at an average price of $12.1619, according to a Form 4 filing.

NYSE
51 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath's CEO and Chairman, Daniel Dines, sold 45,000 shares of Class A Common Stock at an average price of $12.0284, according to a Form 4 filing with the SEC.

NYSE
52 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells Shares Under 10b5-1 Plan
UiPath CEO Daniel Dines sold 14,900 shares of Class A Common Stock at an average price of $12.0077 per share on May 6, 2025, under a pre-arranged 10b5-1 trading plan.

NYSE
53 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells Shares Under 10b5-1 Plan
UiPath CEO Daniel Dines sold 24,979 shares of Class A Common Stock at an average price of $12.0279 on May 5, 2025, under a pre-arranged 10b5-1 trading plan.

NYSE
56 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock at an average price of $12.0152, according to a Form 4 filing with the SEC.

NYSE
56 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath COO & CFO Ashim Gupta Sells Shares Under 10b5-1 Plan
Ashim Gupta, COO & CFO of UiPath, sold 99,300 shares of Class A Common Stock on May 1, 2025, under a pre-arranged 10b5-1 trading plan.

NYSE
57 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Sells 45,000 Shares Under 10b5-1 Plan
UiPath's CEO, Daniel Dines, executed a sale of 45,000 shares of Class A Common Stock at an average price of $12.0058, as part of a pre-arranged trading plan.

NYSE
81 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Sells 12,500 Shares Under 10b5-1 Plan
UiPath's Chief Accounting Officer, Hitesh Ramani, sold 12,500 shares of Class A Common Stock at an average price of $10.1858, as part of a pre-arranged trading plan.

NYSE
85 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Brad Brubaker Reports Stock Disposal for Tax Obligations
Brad Brubaker, GC & Chief Legal Officer of UiPath, reports disposing of shares to cover tax obligations arising from vested restricted stock units.

NYSE
85 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath COO & CFO Ashim Gupta Reports Tax-Related Stock Disposal
Ashim Gupta, COO & CFO of UiPath, reports the disposal of shares to cover tax obligations upon the vesting of restricted stock units.

NYSE
85 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Disposes of Shares to Cover Tax Obligations
Hitesh Ramani, Chief Accounting Officer of UiPath, disposed of 22,595 shares of Class A Common Stock on April 1, 2025, to cover tax obligations arising from the vesting of restricted stock units.

NYSE
95 days, 12 hours ago 
PATH
Uipath, INC
10-K: UiPath's FY25 Revenue Climbs 9% Amid Strategic Shifts and AI Investments
UiPath reports a 9% increase in revenue for fiscal year 2025, driven by subscription growth and strategic investments in AI, while navigating leadership changes and macroeconomic headwinds.
Worse than expected
 

NYSE
101 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Reports Stock Award
Hitesh Ramani, Chief Accounting Officer of UiPath, reports the acquisition of 93,065 shares of Class A Common Stock through Restricted Stock Units (RSUs).

NYSE
101 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath COO & CFO Ashim Gupta Reports Acquisition of 288,321 Shares of Class A Common Stock
Ashim Gupta, COO & CFO of UiPath, reports acquiring 288,321 shares of Class A Common Stock through Restricted Stock Units (RSUs) on March 14, 2025.

NYSE
101 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath GC & Chief Legal Officer Brad Brubaker Reports Acquisition of Restricted Stock Units
Brad Brubaker, GC & Chief Legal Officer of UiPath, reports the acquisition of 145,985 Restricted Stock Units (RSUs) on March 14, 2025.

NYSE
102 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Daniel Dines Converts 5 Million Class B Shares to Class A Under 10b5-1 Trading Plan
UiPath's CEO, Daniel Dines, converted 5 million Class B shares to Class A shares on March 13, 2025, under a pre-arranged trading plan.

NYSE
107 days, 13 hours ago 
PATH
Uipath, INC
8-K: UiPath Reports Q4 and Full Year Fiscal 2025 Financial Results; Announces Acquisition of Peak AI
UiPath announces its Q4 and full year fiscal 2025 results, highlighting revenue growth, ARR increase, and the acquisition of Peak AI to enhance its AI capabilities.
Delay expected
 
Worse than expected
 

NYSE
120 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Sells 12,500 Shares Under 10b5-1 Plan
UiPath's Chief Accounting Officer, Hitesh Ramani, sold 12,500 shares of Class A Common Stock at an average price of $12.6759, according to a Form 4 filing.

NYSE
140 days, 11 hours ago 
PATH
Uipath, INC
SCHEDULE 13G/A: Vanguard Group Discloses 10.22% Passive Stake in UiPath Inc.
The Vanguard Group has reported a 10.22% beneficial ownership stake in UiPath Inc., holding 47,754,958 shares as of January 31, 2025, as a passive investor.

NYSE
168 days, 2 hours ago 
PATH
Uipath, INC
SCHEDULE 13G/A: ARK Investment Management Updates UiPath Stake, Reports 4.48% Beneficial Ownership
ARK Investment Management LLC has filed an Amendment No. 4 to its Schedule 13G, disclosing a 4.48% beneficial ownership stake in UiPath, Inc.'s Class A common stock as of September 30, 2024.

NYSE
172 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Reports Stock Transactions
Hitesh Ramani, Chief Accounting Officer of UiPath, reports the disposal and acquisition of Class A Common Stock on January 2nd and 3rd, 2025.

NYSE
172 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath COO & CFO Ashim Gupta Reports Stock Transactions
Ashim Gupta, COO & CFO of UiPath, reports the disposition and acquisition of Class A Common Stock on January 2nd and 3rd, 2025.

NYSE
172 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Brad Brubaker Reports Stock Transaction
Brad Brubaker, GC & Chief Legal Officer of UiPath, reports the disposal of 41,966 shares to cover tax obligations related to vested restricted stock units.

NYSE
198 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath COO & CFO Ashim Gupta Sells 55,000 Shares Under 10b5-1 Plan
UiPath's COO & CFO, Ashim Gupta, sold 55,000 shares of Class A Common Stock at an average price of $15.6127 per share under a pre-arranged 10b5-1 trading plan.

NYSE
203 days, 9 hours ago 
PATH
Uipath, INC
10-Q: UiPath Reports 9% Revenue Growth in Q3 2025, Driven by Subscription Services
UiPath's Q3 2025 results show a 9% year-over-year revenue increase, fueled by a strong performance in subscription services, despite a decrease in license revenue.
Worse than expected
 
Capital raise
 

NYSE
204 days, 12 hours ago 
PATH
Uipath, INC
8-K: UiPath Reports Strong Q3 Fiscal 2025 Results, Driven by AI and Automation Growth
UiPath's Q3 fiscal 2025 results show a 9% year-over-year revenue increase to $355 million and a 17% increase in ARR to $1.607 billion, highlighting the company's growth in the AI-powered automation market.
Better than expected
 

NYSE
263 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath COO Ashim Gupta Reports Sale of Shares Under 10b5-1 Plan
UiPath's COO & CFO, Ashim Gupta, reported the sale of 47,227 shares of Class A Common Stock on October 3, 2024, under a pre-arranged 10b5-1 trading plan.

NYSE
263 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Sells 25,000 Shares Under 10b5-1 Plan
UiPath's Chief Accounting Officer, Hitesh Ramani, sold 25,000 shares of Class A Common Stock at an average price of $11.9977, executed under a pre-arranged 10b5-1 trading plan.

NYSE
268 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath COO & CFO Ashim Gupta Reports Changes in Beneficial Ownership
Ashim Gupta, COO & CFO of UiPath, reports the acquisition and disposal of Class A Common Stock due to tax obligations and vesting of restricted stock units.

NYSE
268 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Reports Stock Transactions
Hitesh Ramani, Chief Accounting Officer of UiPath, reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units.

NYSE
268 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath GC & Chief Legal Officer Brad Brubaker Reports Stock Transactions
Brad Brubaker, GC & Chief Legal Officer of UiPath, reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units.

NYSE
283 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath COO Ashim Gupta Sells Shares Under 10b5-1 Plan
UiPath's COO & CFO, Ashim Gupta, executed sales of Class A Common Stock on September 13, 2024, under a pre-arranged Rule 10b5-1 trading plan.

NYSE
287 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath Chief Accounting Officer Hitesh Ramani Sells $25,000 in Class A Common Stock
Hitesh Ramani, Chief Accounting Officer of UiPath, sold 25,000 shares of Class A Common Stock on September 11, 2024, under a pre-arranged Rule 10b5-1 trading plan.

NYSE
294 days, 12 hours ago 
PATH
Uipath, INC
10-Q: UiPath Reports 10% Revenue Growth in Q2 2025, Driven by Subscription Services
UiPath's Q2 2025 results show a 10% year-over-year revenue increase, fueled by strong growth in subscription services, despite a decrease in license revenue.
Worse than expected
 

NYSE
294 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath Director Somasegar Sivaramakichenane Reports Acquisition of 47,694 Class A Common Stock Shares
Director Somasegar Sivaramakichenane reports acquiring 47,694 shares of UiPath's Class A Common Stock through a grant of Restricted Stock Units (RSUs).

NYSE
295 days, 13 hours ago 
PATH
Uipath, INC
8-K: UiPath Announces Q2 Fiscal 2025 Results, Board and Leadership Changes, and $500 Million Stock Repurchase Expansion
UiPath reported a 10% year-over-year revenue increase to $316 million and a 19% increase in ARR to $1.551 billion for Q2 fiscal 2025, alongside leadership changes and a stock repurchase program expansion.
Better than expected
 

NYSE
353 days, 22 hours ago 
PATH
Uipath, INC
8-K: UiPath Announces Restructuring Plan Involving 10% Workforce Reduction
UiPath is implementing a restructuring plan that includes a 10% reduction in its global workforce to improve operational efficiency and focus on AI.

NYSE
360 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Disposes of Shares to Cover Tax Obligations
Hitesh Ramani, Chief Accounting Officer of UiPath, disposed of 21,289 shares of Class A Common Stock on July 1, 2024, to cover tax obligations arising from the vesting of restricted stock units.

NYSE
360 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath CFO Ashim Gupta Reports Stock Transactions
UiPath's Chief Financial Officer, Ashim Gupta, reported the disposal of shares to cover tax obligations and also reports shares held by trust.

NYSE
360 days, 13 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Brad Brubaker Disposes of Shares to Cover Tax Obligations
Brad Brubaker, GC & Chief Legal Officer of UiPath, disposed of 22,404 shares to cover tax obligations arising from the vesting of restricted stock units.

NYSE
366 days, 13 hours ago 
PATH
Uipath, INC
8-K: UiPath Stockholders Approve Director Elections and Executive Compensation at Annual Meeting
UiPath's annual meeting saw shareholders approve the election of eight directors, executive compensation, and the ratification of KPMG as the company's auditor.

NYSE
368 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath Director Richard Wong Reports Share Acquisition and Corrects Previous Filing Error
Director Richard Wong reports acquisition of shares via Restricted Stock Units (RSUs) and corrects an administrative error in a previous Form 4 filing.

NYSE
368 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath Director Philippe Botteri Receives Stock Grant
Philippe Botteri, a director at UiPath, received a grant of Class A Common Stock and Restricted Stock Units (RSUs) on June 20, 2024.

NYSE
368 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath Director June Yang Reports Acquisition of Shares
Director June Yang reports acquisition of UiPath Class A Common Stock and Restricted Stock Units (RSUs) on June 20, 2024.

NYSE
368 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath Director Karenann Terrell Receives Stock Grant
Director Karenann Terrell received a grant of 17,021 Restricted Stock Units (RSUs) from UiPath, Inc. on June 20, 2024.

NYSE
368 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath Director Daniel D. Springer Reports Acquisition of Restricted Stock Units
Director Daniel D. Springer reports the acquisition of 17,021 Restricted Stock Units (RSUs) of UiPath, Inc. on June 20, 2024.

NYSE
368 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath Director Laela Sturdy Receives Stock Grant
Laela Sturdy, a director at UiPath, acquired 17,021 shares of Class A Common Stock through a grant on June 20, 2024.

NYSE
368 days, 10 hours ago 
PATH
Uipath, INC
Form 4: UiPath Director Michael Lawrence Gordon Reports Acquisition of Restricted Stock Units
Director Michael Lawrence Gordon reports the acquisition of 17,021 Restricted Stock Units (RSUs) in UiPath, Inc.

NYSE
378 days, 13 hours ago 
PATH
Uipath, INC
4/A: UiPath Executive Robert Enslin Corrects Shareholding Disclosure After Tax Obligation
Robert Enslin, former CEO and Director of UiPath, files an amended Form 4 to correct the number of shares beneficially owned following a transaction related to tax obligations from vested restricted stock units.

NYSE
389 days, 12 hours ago 
PATH
Uipath, INC
10-Q: UiPath Reports 16% Revenue Growth and Strong Cash Flow in Q1 2025
UiPath's first quarter of fiscal year 2025 shows a 16% year-over-year revenue increase and strong cash flow from operations.

NYSE
394 days, 12 hours ago 
PATH
Uipath, INC
DEFA14A: UiPath CEO Robert Enslin Resigns, Founder Daniel Dines Returns to Helm
Robert Enslin resigned as UiPath's CEO, with founder Daniel Dines stepping back into the role, effective June 1, 2024.

NYSE
394 days, 13 hours ago 
PATH
Uipath, INC
8-K: UiPath CEO Robert Enslin Resigns, Founder Daniel Dines Returns to Helm
UiPath's CEO, Robert Enslin, has resigned, and founder Daniel Dines will take over the role effective June 1, 2024.
Worse than expected
 

NYSE
394 days, 13 hours ago 
PATH
Uipath, INC
8-K: UiPath Reports Strong Q1 Fiscal 2025 Results Amidst Leadership Transition
UiPath announced its Q1 fiscal 2025 results, showcasing a 16% year-over-year revenue increase and a 21% increase in ARR, while also announcing a CEO transition.
Worse than expected
 

NYSE
406 days, 12 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Robert Enslin Reports Stock Transaction
UiPath's CEO, Robert Enslin, reports the disposition of 40,005 shares to cover tax obligations related to vested restricted stock units.

NYSE
414 days, 10 hours ago 
PATH
Uipath, INC
8-K: UiPath Invests $35.2 Million in AI Startup H.AI
UiPath has agreed to invest approximately $35.2 million in H.AI, a France-based artificial intelligence company, through a combination of cash and convertible bonds.

NYSE
414 days, 12 hours ago 
PATH
Uipath, INC
DEFA14A: UiPath, Inc. Files Definitive Proxy Statement
UiPath, Inc. has filed a definitive proxy statement with the SEC regarding its upcoming shareholder meeting.

NYSE
414 days, 12 hours ago 
PATH
Uipath, INC
DEF 14A: UiPath Sets Date for 2024 Annual Stockholders Meeting, Outlines Key Proposals
UiPath's annual stockholders meeting will be held virtually on June 20, 2024, to vote on director elections, executive compensation, and the ratification of KPMG LLP as the independent auditor.
Worse than expected
 

NYSE
415 days, 9 hours ago 
PATH
Uipath, INC
Form 4: UiPath CFO Ashim Gupta Sells Shares Under 10b5-1 Plan
UiPath's Chief Financial Officer, Ashim Gupta, executed sales of Class A Common Stock on May 6, 2024, under a pre-arranged 10b5-1 trading plan.

NYSE
444 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CFO Ashim Gupta Sells Shares Under 10b5-1 Plan, Acquires Restricted Stock Units
UiPath's Chief Financial Officer, Ashim Gupta, executed sales of Class A Common Stock under a pre-arranged 10b5-1 trading plan and acquired restricted stock units.

NYSE
444 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Robert Enslin Reports Acquisition of Restricted Stock Units
UiPath CEO Robert Enslin reports the acquisition of 652,173 Restricted Stock Units (RSUs) on April 5, 2024, according to a Form 4 filing with the SEC.

NYSE
444 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Reports Stock Award
Hitesh Ramani, Chief Accounting Officer of UiPath, reports the acquisition of 52,173 shares of Class A Common Stock through Restricted Stock Units (RSUs).

NYSE
444 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath GC & Chief Legal Officer Brad Brubaker Reports Stock Award
Brad Brubaker, General Counsel & Chief Legal Officer of UiPath, Inc., reports the acquisition of 182,608 shares of Class A Common Stock through Restricted Stock Units (RSUs) on April 5, 2024.

NYSE
450 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Hitesh Ramani Reports Tax-Related Stock Disposal
Hitesh Ramani, Chief Accounting Officer of UiPath, disposed of 19,068 shares of Class A Common Stock on April 1, 2024, to cover tax obligations related to vesting restricted stock units.

NYSE
450 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CFO Ashim Gupta Reports Stock Transactions
UiPath's Chief Financial Officer, Ashim Gupta, reports the disposal of shares to cover tax obligations and discloses beneficial ownership.

NYSE
450 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath CEO Robert Enslin Reports Stock Transaction
UiPath's CEO, Robert Enslin, reports the disposal of 22,332 shares to cover tax obligations.

NYSE
450 days, 11 hours ago 
PATH
Uipath, INC
Form 4: UiPath Executive Brad Brubaker Reports Tax-Related Stock Disposal
Brad Brubaker, GC & Chief Legal Officer of UiPath, Inc., reports the disposal of shares to cover tax obligations arising from vested restricted stock units.

NYSE
457 days, 12 hours ago 
PATH
Uipath, INC
10-K: UiPath Files 10-K Report, Details Financial Performance and Strategic Initiatives
UiPath's 10-K filing for fiscal year 2024 highlights a year of growth, strategic shifts, and a focus on AI-powered automation.
Worse than expected
 

NYSE
465 days, 8 hours ago 
PATH
Uipath, INC
Form 4: UiPath CFO Ashim Gupta Sells 16,000 Shares Under 10b5-1 Plan
UiPath's Chief Financial Officer, Ashim Gupta, executed a sale of 16,000 shares of Class A Common Stock on March 15, 2024, as part of a pre-arranged trading plan.

NYSE
471 days, 13 hours ago 
PATH
Uipath, INC
8-K: UiPath Achieves First Quarter of GAAP Profitability, Reports Strong Fiscal 2024 Results
UiPath reported record quarterly revenue and its first quarter of GAAP profitability as a public company, alongside a 22% year-over-year increase in ARR.
Better than expected
 

PATH 
Uipath, INC 
NYSE

10-K: UiPath Files 10-K Report, Details Financial Performance and Strategic Initiatives

Sentiment:
 Annual Results
 27 March 2024 5:26 PM

UiPath's 10-K filing for fiscal year 2024 highlights a year of growth, strategic shifts, and a focus on AI-powered automation.

Worse than expected
  Despite revenue growth, the company reported a net loss for the year, indicating that profitability is still a challenge. 

Summary
  • UiPath's 10-K filing for the fiscal year ended January 31, 2024, reveals a 24% increase in revenue to $1.308 billion and a 22% increase in ARR to $1.463 billion.
  • The company achieved a gross margin of 85% for the year, up from 83% in the previous year.
  • UiPath's customer base remained relatively stable at approximately 10,830 customers.
  • The company's cash, cash equivalents, and marketable securities totaled $1.88 billion as of January 31, 2024.
  • A stock repurchase program was authorized, allowing for up to $500 million in share repurchases, with $102.6 million of shares repurchased during the year.
  • The company is focusing on AI-powered automation and has made significant investments in research and development.
  • UiPath is streamlining its go-to-market approach to improve market segmentation and customer experience.
  • The company is also expanding its platform through strategic acquisitions and partnerships.
Sentiment

Score: 6

Explanation: The document presents a mixed picture. While there is strong revenue and ARR growth, the company is still operating at a loss and faces significant risks. The strategic focus on AI and the stock repurchase program are positive signs, but the overall sentiment is cautiously optimistic.

Positives
  • UiPath experienced significant revenue and ARR growth in fiscal year 2024.
  • The company's gross margin improved, indicating increased profitability.
  • UiPath has a strong cash position, providing financial flexibility.
  • The stock repurchase program demonstrates confidence in the company's future.
  • The company is actively investing in AI and machine learning, positioning it for future growth.
  • UiPath is focused on expanding its platform and customer base.
Negatives
  • The company incurred a net loss of $89.9 million for the fiscal year, despite achieving GAAP profitability in the fourth quarter.
  • Operating expenses remain high, impacting overall profitability.
  • The company is subject to various risks, including competition, macroeconomic conditions, and regulatory compliance.
  • The dual-class stock structure concentrates voting control with a single individual.
  • The company relies on third-party cloud providers, which could pose risks.
  • The company is subject to stringent and evolving data privacy and security laws.
Risks
  • UiPath may not achieve or sustain consistent profitability due to significant operating expenses.
  • The company faces intense competition in the automation market.
  • Macroeconomic conditions and geopolitical tensions could adversely affect the business.
  • The company's reliance on a single platform could be a risk if it fails to meet customer demands.
  • Data privacy and cybersecurity risks could lead to regulatory actions and financial losses.
  • The dual-class stock structure limits stockholders' ability to influence decisions.
  • The company's international operations are subject to various operational challenges.
  • The company is subject to anti-corruption, anti-bribery, and anti-money laundering laws.
Future Outlook

UiPath intends to continue investing in research and development, expanding its platform, and growing its customer base, with a focus on AI-powered automation and strategic acquisitions.

Management Comments
  • The company sells automation not merely as a tool, but as a way of operating and innovating.
  • UiPath emphasizes the ability of its platform to deliver meaningful business outcomes for its customers.
  • The company aspires to be the defining business automation platform, advancing the evolution of automation and AI as a way of working and a catalyst for continuous reinvention.
Industry Context

The document highlights the competitive landscape of the automation market, with UiPath competing against enterprise platform vendors, RPA software providers, and adjacent automation companies. The company is positioning itself as a leader in AI-powered automation, which is a growing trend in the industry.

Comparison to Industry Standards
  • UiPath's revenue growth of 24% is strong compared to some established software companies, but may be lower than some high-growth SaaS companies.
  • The company's gross margin of 85% is competitive within the software industry.
  • UiPath's focus on AI and machine learning aligns with industry trends, but the company faces competition from other players in this space.
  • The company's customer base of approximately 10,830 is significant, but it is important to compare this to other companies in the automation space.
  • The company's dollar-based net retention rate of 119% indicates strong customer loyalty and expansion, but it is important to compare this to industry benchmarks.
Stakeholder Impact
  • Shareholders may be impacted by the company's stock repurchase program and the volatility of the stock price.
  • Employees may be impacted by changes in management and potential restructuring activities.
  • Customers may benefit from the company's focus on AI-powered automation and platform enhancements.
  • Suppliers and partners may be impacted by the company's strategic shifts and growth initiatives.
Next Steps
  • UiPath will continue to invest in research and development to enhance its platform.
  • The company will focus on expanding its customer base and increasing sales to existing customers.
  • UiPath will continue to evaluate strategic acquisition opportunities.
  • The company will continue to refine its partner program to facilitate partner growth.
Legal Proceedings
  • UiPath and certain of its officers are parties to a securities class action lawsuit alleging material misstatements and omissions.
  • UiPath and certain of its officers and directors are parties to multiple shareholder derivative lawsuits alleging breach of fiduciary duties and other misconduct.
Related Party Transactions
  • UiPath has at times made use of an aircraft owned by Daniel Dines, a co-founder and former CEO, through a special purpose LLC.
Key Dates
  • 2005: UiPath was first established in Bucharest, Romania.
  • June 9, 2015: UiPath was incorporated in Delaware.
  • July 7, 2023: Daniel Dines notified the board of his resignation as Co-CEO, effective January 31, 2024.
  • October 30, 2023: The maturity date of the $200 million senior secured revolving credit facility.
  • January 31, 2024: End of the fiscal year, Daniel Dines resigned as Co-CEO, Robert Enslin became sole CEO.
  • February 1, 2024: Robert Enslin assumed the role of sole CEO, Daniel Dines became Chief Innovation Officer.
  • March 21, 2024: Date of share count information provided in the document.
Keywords
automation, AI, RPA, machine learning, ARR, SaaS, digital transformation, business automation, cloud, enterprise software

PATH 
Uipath, INC 
NYSE
Sector: TBD
 
Filings with Classifications
Worse than expected
10 June 2025 5:28 PM

Insider Trading Report
  • The sale of shares by a high-ranking executive and significant shareholder, even under a Rule 10b5-1 plan, is generally viewed as a negative signal by the market, as it reduces the insider's direct stake in the company.
Worse than expected
5 June 2025 4:13 PM

SEC Form 4
  • The sale of shares by a key executive like the CEO, even if pre-planned, can be interpreted as a lack of confidence or a signal that the stock may not appreciate significantly in the near term, which is generally viewed as a negative indicator for investors.
Better than expected
29 May 2025 4:16 PM

Quarterly Report
  • First quarter results exceeded the company's guidance on both the top line (revenue) and bottom line (non-GAAP operating income).
  • Achieved significant year-over-year expansion in non-GAAP operating margin.
Worse than expected
13 May 2025 4:57 PM

Proxy Statement
  • The company's gross margin decreased from 85% in fiscal year 2024 to 83% in fiscal year 2025.
  • The company's cash and cash equivalents, restricted cash, and marketable securities decreased from $1,880.3 million as of January 31, 2024 to $1,724.1 million as of January 31, 2025.
Worse than expected
24 March 2025 5:27 PM

Annual Report on Form 10-K
  • Revenue growth slowed to 9% compared to prior periods.
  • Gross margin decreased from 85% to 83%.
Worse than expected
12 March 2025 4:23 PM

Earnings Release
  • The financial outlook for fiscal year 2026 reflects increasing global macro economic uncertainty, particularly in the U.S. public sector, resulting in lower revenue and ARR projections than previously anticipated.
Delay expected
12 March 2025 4:23 PM

Earnings Release
  • The restructuring costs are now expected to be incurred by the end of the second quarter of fiscal year 2026, extending the original timeline.
Capital raise
6 December 2024 7:13 PM

Quarterly Report
  • The company may be required to seek additional equity or debt financing in the future.
Worse than expected
6 December 2024 7:13 PM

Quarterly Report
  • The company's gross margin decreased to 82% for the quarter, down from 85% in the same quarter of the previous year.
  • The company reported a net loss of $10.7 million for the quarter and $125.5 million year-to-date.
  • Interest income decreased by 31% for the quarter due to lower cash balances and decreased interest rates.
Better than expected
5 December 2024 4:14 PM

Quarterly Report
  • The company's third quarter results exceeded expectations, reflecting improved execution and customer response to their new vision.
Worse than expected
6 September 2024 5:13 PM

Quarterly Report
  • The company's gross margin decreased from 83% to 80% due to increased costs in subscription services.
  • The operating loss increased from $77.6 million to $103.3 million year-over-year.
  • License revenue decreased by 6% year-over-year.
Better than expected
5 September 2024 4:17 PM

Quarterly Report
  • The company's ARR growth of 19% year-over-year exceeded expectations.
  • The company's non-GAAP adjusted free cash flow of $49 million was better than anticipated.
  • The company raised its full year profitability guidance.
Worse than expected
29 May 2024 4:25 PM

Executive Change Announcement
  • The unexpected resignation of the CEO is generally viewed negatively by the market.
Worse than expected
29 May 2024 4:18 PM

Quarterly Report
  • The company has lowered its full year revenue and operating margin guidance due to increased deal scrutiny and lengthening sales cycles.
Worse than expected
9 May 2024 5:00 PM

Proxy Statement
  • The company did not achieve 100% of its iARR target for fiscal year 2024, achieving 82% of the target.
Worse than expected
27 March 2024 5:26 PM

Annual Results
  • Despite revenue growth, the company reported a net loss for the year, indicating that profitability is still a challenge.
Better than expected
13 March 2024 4:17 PM

Quarterly Report
  • The company achieved its first quarter of GAAP profitability as a public company, which is better than expected.
  • The company's revenue and ARR growth exceeded expectations.

Disclaimer: This summary was generated by artificial intelligence and its accuracy is not guaranteed. The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.